Cargando…

Health‐related quality of life in patients with multiple system atrophy using the EQ‐5D‐5L

BACKGROUND: Multiple system atrophy (MSA) is an incurable neurodegenerative disease. We aimed to investigate the health‐related quality of life (HRQoL) and the determinants of HRQoL in patients with MSA. METHODS: The five‐level EuroQol five‐dimensional questionnaire (EQ‐5D‐5L) was used to evaluate p...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Yi, Zhang, Lingyu, Wei, Qianqian, Ou, Ruwei, Hou, Yanbing, Liu, Kuncheng, Lin, Junyu, Yang, Tianmi, Shang, Huifang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575615/
https://www.ncbi.nlm.nih.gov/pubmed/36124355
http://dx.doi.org/10.1002/brb3.2774
_version_ 1784811348925874176
author Xiao, Yi
Zhang, Lingyu
Wei, Qianqian
Ou, Ruwei
Hou, Yanbing
Liu, Kuncheng
Lin, Junyu
Yang, Tianmi
Shang, Huifang
author_facet Xiao, Yi
Zhang, Lingyu
Wei, Qianqian
Ou, Ruwei
Hou, Yanbing
Liu, Kuncheng
Lin, Junyu
Yang, Tianmi
Shang, Huifang
author_sort Xiao, Yi
collection PubMed
description BACKGROUND: Multiple system atrophy (MSA) is an incurable neurodegenerative disease. We aimed to investigate the health‐related quality of life (HRQoL) and the determinants of HRQoL in patients with MSA. METHODS: The five‐level EuroQol five‐dimensional questionnaire (EQ‐5D‐5L) was used to evaluate patients’ HRQoL. The results of HRQoL were indicated by the EQ‐5D‐5L index values and visual analog scale (EQ VAS) scores. Specific scales were used to measure disease severity, cognition, frontal lobe function, anxiety, depression, fatigue, and sleep disorders. The beta mixture model and the linear regression model were used to explore the determinants of HRQoL in patients with MSA. RESULTS: A total of 205 patients with cerebellar variants (MSA‐C; 53.9%) and 175 patients with parkinsonian variants (MSA‐P; 46.1%) were included in this cross‐sectional study. The mean values of the EQ‐5D‐5L index values and EQ VAS scores were .558 and 59.5, respectively. Problem with mobility was the problem reported by the highest proportion of patients (92.1%), followed by problems with usual activities (88.7%), self‐care (81.3%), anxiety/depression (72.1%), and pain/discomfort (53.9%). The determinants of the lower EQ‐5D‐5L index values in patients with MSA were greater disease severity, fatigue, Parkinson's disease‐related sleep problems (PD‐SP), depressive mood, and anxious mood. Greater disease severity, fatigue, and depressive mood were associated with lower EQ VAS scores. CONCLUSION: The problem reported most frequently by Chinese individuals with MSA was mobility. In addition to the greater disease severity of MSA, fatigue, PD‐SP, depression, and anxiety were determinants of poor HRQoL.
format Online
Article
Text
id pubmed-9575615
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-95756152022-10-18 Health‐related quality of life in patients with multiple system atrophy using the EQ‐5D‐5L Xiao, Yi Zhang, Lingyu Wei, Qianqian Ou, Ruwei Hou, Yanbing Liu, Kuncheng Lin, Junyu Yang, Tianmi Shang, Huifang Brain Behav Original Articles BACKGROUND: Multiple system atrophy (MSA) is an incurable neurodegenerative disease. We aimed to investigate the health‐related quality of life (HRQoL) and the determinants of HRQoL in patients with MSA. METHODS: The five‐level EuroQol five‐dimensional questionnaire (EQ‐5D‐5L) was used to evaluate patients’ HRQoL. The results of HRQoL were indicated by the EQ‐5D‐5L index values and visual analog scale (EQ VAS) scores. Specific scales were used to measure disease severity, cognition, frontal lobe function, anxiety, depression, fatigue, and sleep disorders. The beta mixture model and the linear regression model were used to explore the determinants of HRQoL in patients with MSA. RESULTS: A total of 205 patients with cerebellar variants (MSA‐C; 53.9%) and 175 patients with parkinsonian variants (MSA‐P; 46.1%) were included in this cross‐sectional study. The mean values of the EQ‐5D‐5L index values and EQ VAS scores were .558 and 59.5, respectively. Problem with mobility was the problem reported by the highest proportion of patients (92.1%), followed by problems with usual activities (88.7%), self‐care (81.3%), anxiety/depression (72.1%), and pain/discomfort (53.9%). The determinants of the lower EQ‐5D‐5L index values in patients with MSA were greater disease severity, fatigue, Parkinson's disease‐related sleep problems (PD‐SP), depressive mood, and anxious mood. Greater disease severity, fatigue, and depressive mood were associated with lower EQ VAS scores. CONCLUSION: The problem reported most frequently by Chinese individuals with MSA was mobility. In addition to the greater disease severity of MSA, fatigue, PD‐SP, depression, and anxiety were determinants of poor HRQoL. John Wiley and Sons Inc. 2022-09-19 /pmc/articles/PMC9575615/ /pubmed/36124355 http://dx.doi.org/10.1002/brb3.2774 Text en © 2022 The Authors. Brain and Behavior published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Xiao, Yi
Zhang, Lingyu
Wei, Qianqian
Ou, Ruwei
Hou, Yanbing
Liu, Kuncheng
Lin, Junyu
Yang, Tianmi
Shang, Huifang
Health‐related quality of life in patients with multiple system atrophy using the EQ‐5D‐5L
title Health‐related quality of life in patients with multiple system atrophy using the EQ‐5D‐5L
title_full Health‐related quality of life in patients with multiple system atrophy using the EQ‐5D‐5L
title_fullStr Health‐related quality of life in patients with multiple system atrophy using the EQ‐5D‐5L
title_full_unstemmed Health‐related quality of life in patients with multiple system atrophy using the EQ‐5D‐5L
title_short Health‐related quality of life in patients with multiple system atrophy using the EQ‐5D‐5L
title_sort health‐related quality of life in patients with multiple system atrophy using the eq‐5d‐5l
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575615/
https://www.ncbi.nlm.nih.gov/pubmed/36124355
http://dx.doi.org/10.1002/brb3.2774
work_keys_str_mv AT xiaoyi healthrelatedqualityoflifeinpatientswithmultiplesystematrophyusingtheeq5d5l
AT zhanglingyu healthrelatedqualityoflifeinpatientswithmultiplesystematrophyusingtheeq5d5l
AT weiqianqian healthrelatedqualityoflifeinpatientswithmultiplesystematrophyusingtheeq5d5l
AT ouruwei healthrelatedqualityoflifeinpatientswithmultiplesystematrophyusingtheeq5d5l
AT houyanbing healthrelatedqualityoflifeinpatientswithmultiplesystematrophyusingtheeq5d5l
AT liukuncheng healthrelatedqualityoflifeinpatientswithmultiplesystematrophyusingtheeq5d5l
AT linjunyu healthrelatedqualityoflifeinpatientswithmultiplesystematrophyusingtheeq5d5l
AT yangtianmi healthrelatedqualityoflifeinpatientswithmultiplesystematrophyusingtheeq5d5l
AT shanghuifang healthrelatedqualityoflifeinpatientswithmultiplesystematrophyusingtheeq5d5l